We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Congress Queries Drug Makers Over Measures Against Counterfeits

Law360 (January 19, 2004, 12:00 AM EST) -- U.S. congressional lawmakers have sent letters to five of the nation's largest drug makers, asking them to explain what they are doing to stop counterfeit drugs from entering the market.

The House Energy and Commerce Committee sent letters to Eli Lilly and Co., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer Inc. and Serono requesting the information by Feb. 16.

"We are interested in any ongoing efforts or plans by your company to prevent counterfeiting and diversion of your drugs, and to prevent any involvement of your products...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.